211 related articles for article (PubMed ID: 12187329)
1. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells.
Meinhardt G; Eppinger E; Schmidmaier R
Anticancer Drugs; 2002 Aug; 13(7):725-33. PubMed ID: 12187329
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
Meinhardt G; Roth J; Totok G
Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes.
Jiang Y; Sakane F; Kanoh H; Walsh JP
Biochem Pharmacol; 2000 Apr; 59(7):763-72. PubMed ID: 10718334
[TBL] [Abstract][Full Text] [Related]
4. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation.
Tonetti DA; Horio M; Collart FR; Huberman E
Cell Growth Differ; 1992 Oct; 3(10):739-45. PubMed ID: 1445803
[TBL] [Abstract][Full Text] [Related]
6. Phorbol ester-resistant monoblastoid leukemia cells with a functional mitogen-activated protein kinase cascade but without responsive protein tyrosine phosphatases.
Seimiya H; Sawabe T; Toho M; Tsuruo T
Oncogene; 1995 Nov; 11(10):2047-54. PubMed ID: 7478524
[TBL] [Abstract][Full Text] [Related]
7. Effects of the diacylglycerol kinase inhibitor, R59022, on TSH-stimulated iodide organification in porcine thyroid cells.
Matowe WC; Ginsberg J
Pharmacology; 1996 Dec; 53(6):376-83. PubMed ID: 9032802
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
Chelliah J; Freemerman AJ; Wu-Pong S; Jarvis WD; Grant S
Biochem Pharmacol; 1997 Sep; 54(5):563-73. PubMed ID: 9337072
[TBL] [Abstract][Full Text] [Related]
9. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
[TBL] [Abstract][Full Text] [Related]
10. Activation of protein kinase C relays distinct signaling pathways in the same cell type: differentiation and caspase-mediated apoptosis.
Meinhardt G; Roth J; Hass R
Cell Death Differ; 2000 Sep; 7(9):795-803. PubMed ID: 11042674
[TBL] [Abstract][Full Text] [Related]
11. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
Wang S; Wang Z; Grant S
Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
[TBL] [Abstract][Full Text] [Related]
12. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells.
Kharbanda S; Saleem A; Emoto Y; Stone R; Rapp U; Kufe D
J Biol Chem; 1994 Jan; 269(2):872-8. PubMed ID: 8288641
[TBL] [Abstract][Full Text] [Related]
13. Defective translocation of protein kinase C in multidrug-resistant HL-60 cells confers a reversible loss of phorbol ester-induced monocytic differentiation.
Slapak CA; Kharbanda S; Saleem A; Kufe DW
J Biol Chem; 1993 Jun; 268(17):12267-73. PubMed ID: 8389757
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
[TBL] [Abstract][Full Text] [Related]
15. Evidence that protein kinase Cepsilon mediates phorbol ester inhibition of calphostin C- and tumor necrosis factor-alpha-induced apoptosis in U937 histiocytic lymphoma cells.
Mayne GC; Murray AW
J Biol Chem; 1998 Sep; 273(37):24115-21. PubMed ID: 9727032
[TBL] [Abstract][Full Text] [Related]
16. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
[TBL] [Abstract][Full Text] [Related]
17. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
Gallagher AP; Burnett AK; Bowen DT; Darley RL
Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
19. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
[TBL] [Abstract][Full Text] [Related]
20. The diacylglycerol kinase inhibitor, R59022, potentiates cholecystokinin-induced enzyme secretion from rabbit pancreatic acini.
Ederveen AG; van Emst-de Vries SE; De Pont JJ; Willems PH
Eur J Biochem; 1990 Mar; 188(2):333-8. PubMed ID: 1690650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
